Does ‘IgG4-related leptomeningitis’ exist?

Shohei Beppu, Taiki Yabumoto, Makoto Kinoshita, Tatsusada Okuno, Kenichi Todo, Naoki Tani, Haruhiko Kishima, Yuichi Motoyama, Eiichi Morii, Hideki MochizukiRinsho 2022 · DOI

Abstract

Leptomeningitis, an inflammation of the meningeal layers, can arise from various systemic autoimmune conditions, most notably IgG4-related disease (IgG4-RD) and Rheumatoid Meningitis (RM). These conditions often present with nearly identical clinical and radiological profiles, leading to significant diagnostic ambiguity. This paper explores the differentiation between these two entities, emphasizing the role of serum anti-cyclic citrullinated peptide (anti-CCP) antibodies and specific histopathological staining. Through a retrospective analysis of a previously reported case and a review of existing literature, the authors argue for a proactive diagnostic strategy to distinguish "silent" rheumatoid meningitis from IgG4-related leptomeningitis.

Introduction

The diagnosis of leptomeningitis often involves navigating a complex landscape of "diagnostic mimicry." While Rheumatoid Meningitis (RM) is traditionally associated with established Rheumatoid Arthritis (RA), it can manifest as a neurological precursor or occur in the complete absence of joint symptoms. This clinical overlap with IgG4-related disease (IgG4-RD) is further complicated by strikingly similar MRI findings. The central question addressed is how clinicians can definitively confirm a diagnosis of IgG4-related leptomeningitis while ruling out rare, non-articular presentations of RM.

Methodology

This study is structured as a "Reply from the Author," utilizing a multi-faceted approach:

  1. Retrospective Case Review: Re-evaluation of a previously reported case of IgG4-related leptomeningitis, specifically focusing on serum anti-CCP antibody levels measured after the initiation of steroid therapy.
  2. Literature Synthesis: A review of 12 key sources to understand the behavior of anti-CCP antibodies in both serum and cerebrospinal fluid (CSF) during immunotherapy.
  3. Comparative Analysis: An assessment of the relative diagnostic utility of serology, imaging, and pathology in differentiating these inflammatory conditions.

Key Insights and Diagnostic Challenges

The "Silent" Presentation of Rheumatoid Meningitis

RM is a "great imitator" in neurology. It can present with cognitive decline or other neurological deficits long before joint pain emerges. In some instances, articular symptoms never develop, making the diagnosis of RM particularly elusive when relying solely on traditional clinical markers of RA.

Dynamics of Anti-CCP Antibodies

A critical finding involves the persistence of serum markers. While corticosteroid treatment may reduce anti-CCP levels within the CSF, serum levels typically remain elevated. This suggests that serum anti-CCP testing remains a robust diagnostic tool even after the commencement of immunosuppressive therapy, providing a window for retrospective diagnostic clarification.

The Role of Histopathology

Given that MRI findings for IgG4-RD and RM are often indistinguishable, meningeal biopsy remains the gold standard. The authors advocate for the routine inclusion of specific IgG4 staining in any biopsy performed for unexplained leptomeningitis, especially when systemic markers for other autoimmune diseases are absent.

Results and Conclusion

In the authors' re-examined case, the anti-CCP antibody test returned negative during the remission phase. Correlating this with literature on antibody persistence, they concluded that RM was unlikely, thereby reinforcing the original diagnosis of IgG4-related leptomeningitis.

To improve diagnostic accuracy in future cases of unexplained leptomeningitis, the following protocol is recommended:

  • Early Serological Testing: Proactive testing for serum anti-CCP antibodies.
  • Meningeal Biopsy: Implementation of biopsy when serology and imaging are inconclusive.
  • Specific Staining: Mandatory IgG4 staining on all meningeal biopsy samples.

Limitations and Future Directions

The primary limitation of the current case review was the timing of the anti-CCP test, which occurred after steroid treatment had begun. Although evidence suggests serum markers persist, pre-treatment testing is preferred. Furthermore, the lack of internationally agreed-upon diagnostic criteria for RM—particularly for non-articular cases—remains a significant hurdle. Future multi-center studies are essential to establish standardized protocols and prevent misdiagnosis in these rare inflammatory diseases.

Summary updated

BibTeX
@inproceedings{beppu2022does,
  author = {Shohei Beppu and Taiki Yabumoto and Makoto Kinoshita and Tatsusada Okuno and Kenichi Todo and Naoki Tani and Haruhiko Kishima and Yuichi Motoyama and Eiichi Morii and Hideki Mochizuki},
  title = {{Does ‘IgG4-related leptomeningitis’ exist?}},
  booktitle = {Rinsho},
  year = {2022},
  doi = {10.5692/clinicalneurol.cn-001803},
}
Figure